- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Новости 257 results
Press Release
апреля 5, 2021
Firm Statement on Free and Fair Elections
Press Release
марта 29, 2021
FDA Acting Policy Director for Office of Therapeutic Biologics and Biosimilars Joins King & Spalding
Press Release
марта 19, 2021
Recent Violence Targeting Asian-Americans
Press Release
марта 16, 2021
King & Spalding Adds International Arbitration Partner Ken Beale
Press Release
февраля 25, 2021
King & Spalding Launches Global Human Capital & Compliance Practice
Press Release
февраля 22, 2021
King & Spalding’s New York Office Adds Financial Services Partner Russell Sacks
Press Release
февраля 3, 2021
King & Spalding Launches Mobile App to Help Lenders Navigate the Private Credit Market
Press Release
февраля 2, 2021
Paul Murphy, Former Chief of Staff to FBI Director, Returns to King & Spalding
Press Release
января 26, 2021
Top Healthcare Partner Richard Zall Joins King & Spalding in New York
Press Release
января 19, 2021
Craig Carpenito, Former U.S. Attorney for the District of New Jersey, Joins King & Spalding
Press Release
января 7, 2021
King & Spalding’s FDA and Life Sciences Team Adds Partner in Washington
Press Release
января 6, 2021
King & Spalding’s Global Human Capital and Compliance Practice Adds Partner in Chicago